Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Carbohydr Res ; 224: 255, 1992 Feb 07.
Article in English | MEDLINE | ID: mdl-1591766

ABSTRACT

A series of 6- and 8-acylamino-4-methylumbelliferyl beta-D-galactopyranosides, beta-D-glucopyranosides, and alpha-L-fucopyranosides having various fatty acid residues were synthesized; 6-(9) and 8-hexadecanoylamino-4-methylumbelliferyl beta-D-galactopyranoside (10) were shown to be substrates for human galactocerebrosidase. Analogs of 9 with shorter acyl residues (octanoyl and butanoyl) were substrates for another type of beta-D-galactosidase, i.e., GM1-ganglioside-beta-D-galactosidase. The specificity of various beta-D-galactosidases for synthetic D-galactopyranosides, differing in the length and position of their acylamide residue, tested with enzyme preparations from patients with two types of glycolipidosis, Krabbe's disease (galactocerebrosidase deficiency) and GM1-beta-galactosidase deficiency), suggested that 9 is a specific substrate for galactocerebrosidase in biochemical tests for Krabbe's disease. Fluorogenic 6-octanoyl- and 6-hexadecanoyl-amino-4-methylumbelliferyl beta-D-glucopyranoside were much less readily hydrolyzed by both human and animal glucocerebrosidase than chromogenic 2-hexadecanoylamino-4-nitrophenyl beta-D-glucopyranoside. Comparison of the hydrolysis of 4-methylumbelliferyl alpha-L-fucopyranoside with that of 6-hexadecanoylamino-4-methylumbelliferyl alpha-L-fucopyranoside by multiple forms of human alpha-L-fucosidase showed that the enzyme is capable of hydrolyzing not only hydrophilic but also synthetic, lipid-like substrates.


Subject(s)
Glycolipids/metabolism , Glycoside Hydrolases/metabolism , Glycosides/metabolism , Lysosomes/enzymology , Umbelliferones/metabolism , Glycoside Hydrolases/isolation & purification , Glycosides/chemistry , Humans , Hydrolysis , Kidney/enzymology , Liver/enzymology , Substrate Specificity , Umbelliferones/chemistry
2.
Biokhimiia ; 54(3): 421-6, 1989 Mar.
Article in Russian | MEDLINE | ID: mdl-2546612

ABSTRACT

It was shown that human alpha-D-galactosidase is represented by multiple forms, only one of which can also split alpha-D-fucoside. Fabry's disease was found to be associated not only with the deficiency of the alpha-D-galactosidase total activity but also with the deficiency of the alpha-D-fucosidase activity. The decrease in the alpha-D-galactosidase activity is due to the lack of two enzyme forms, while the profile of alpha-D-fucosidase multiple forms during isoelectric focusing of human enzyme preparations is modified very little in comparison with the normal one. The deficiency of both enzymes was expressed in most degree in leukocytes as compared to other tissues. The residual activities of alpha-D-galactosidase and alpha-D-fucosidase in leukocytes were equal to 3.5 and 21%, respectively. Since the decrease in the alpha-D-fucosidase activity was not so noticeable as in the alpha-D-galactosidase activity, it may be expected that the determination of the alpha-D-fucosidase activity can no longer be regarded as a reliable test for the diagnosis of Fabry's disease. The data obtained suggest that alpha-D-galactoside and alpha-D-fucoside are split by the same enzyme, the multiple forms of which are characterized by selective specificity towards these substrates.


Subject(s)
Fabry Disease/enzymology , Galactosidases/metabolism , Isoenzymes/metabolism , alpha-Galactosidase/metabolism , alpha-L-Fucosidase/metabolism , Glycosides/chemical synthesis , Humans , Hymecromone/analogs & derivatives , Hymecromone/chemical synthesis , Isoelectric Focusing , Kidney/enzymology , Leukocytes/enzymology , Liver/enzymology , Spleen/enzymology , Substrate Specificity
3.
Biokhimiia ; 53(9): 1539-45, 1988 Sep.
Article in Russian | MEDLINE | ID: mdl-3203114

ABSTRACT

The properties of beta-galactocerebrosidase from human chorionic villi, cultured chorionic villi and cultured skin fibroblasts were compared, using 6-hexadecanoylamino-4-methylumbelliferyl-beta-D-galactopyranoside (HMGaL) as substrate. The effects of bile salt and Triton X-100 on beta-galactocerebrosidase were examined. It was shown that optimization of the HMGaL assay system requires the presence of pure sodium taurocholate and Triton X-100 at concentrations of 4.5 mM and 0.28 mM, respectively. The optimal pH value was found to be equal to 4.5-5.0; Km for the substrate was 0.03 mM. A comparison of beta-galactocerebrosidase from chorionic villi and cultured chorionic villi with the enzyme from skin fibroblasts revealed the similarity of some properties of these enzymes. The experimental results suggest that HMGaL can be used as a substrate for the identification of chorionic villi beta-galactocerebrosidase in an early prenatal diagnosis of Krabbe's disease.


Subject(s)
Chorion/enzymology , Fluorescent Dyes , Galactosidases/analysis , Galactosides , Galactosylceramidase/analysis , Glycosides , Hymecromone , Umbelliferones , Cells, Cultured , Fibroblasts/enzymology , Humans , Hydrogen-Ion Concentration , Hymecromone/analogs & derivatives , Kinetics , Leukodystrophy, Globoid Cell/diagnosis , Substrate Specificity
4.
Bioorg Khim ; 14(8): 1014-26, 1988 Aug.
Article in Russian | MEDLINE | ID: mdl-3146253

ABSTRACT

On the basis of o-acylamino-4-methylumbelliferon, a number of beta-galactosides and beta-glucosides have been synthesized. The fluorogenic compounds obtained differ by the length of acyl residues. 6- and 8-hexadecanoylamino-4-methylumbelliferyl-beta-D-galactopyranosides (6-HMGal and 8-HMGal) are shown to be substrates for human galactocerebroside-beta-D-galactosidase. 6-HMGal analogues with shorter acyl residues, octanoyl (OMGal) and butanoyl (BMGal), were cleaved by another type of beta-galactosidase, GM1-ganglioside-beta-galactosidase. It has been established that 6-hexadecanoylamino-4-methylumbelliferyl-beta-D-glucopyranoside (HMGlc) is cleaved by human and animal glucocerebrosidase much slower than its chromogenic analogue (HMGlc). OMGlc did not exceed HNGlc either, though it is cleaved by glucocerebrosidase faster than HMGlc.


Subject(s)
Fluorescent Dyes , Galactosidases/analysis , Galactosylceramidase/analysis , Glucosidases/analysis , Glucosylceramidase/analysis , Lysosomes/enzymology , beta-Galactosidase/analysis , Catalysis , Chemical Phenomena , Chemistry , Chromatography, Gel , Clinical Enzyme Tests , Galactosides , Galactosylceramidase/deficiency , Glucosides , Glucosylceramidase/deficiency , Humans , Kinetics , Sphingolipidoses/diagnosis , Substrate Specificity , beta-Galactosidase/deficiency
5.
Biokhimiia ; 50(10): 1665-7, 1985 Oct.
Article in Russian | MEDLINE | ID: mdl-3935176

ABSTRACT

A new fluorogenic compound--6-hexadecanoylamino-4-methyl-umbelliferyl-beta-D-gala cto pyranoside (HMGal), a substrate for human galactocerebroside beta-D-galactosidase (HG), has been synthesized. A method for determining the HG activity based on the use of HMGal as a fluorogenic substrate has been developed. The specificity of HMGal hydrolysis by HG has been demonstrated in experiments with enzyme preparations from human skin fibroblasts and leukocytes in normally and in hereditary glycolipidosis (GM1-gangliosidosis and Krabbe's disease). The use of HMGal permits to markedly increase the sensitivity of the method used for determining the HG activity.


Subject(s)
Chromogenic Compounds/chemical synthesis , Clinical Enzyme Tests , Galactosidases/analysis , Galactosylceramidase/analysis , Gangliosidoses/diagnosis , Leukodystrophy, Globoid Cell/diagnosis , Chemical Phenomena , Chemistry , G(M1) Ganglioside , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...